TL;DR
This study uses deep mutational scanning to comprehensively analyze thousands of variants of the human enzyme aspartoacylase (ASPA), revealing a strong link between protein instability, degradation by the cell's quality control system, and cellular toxicity. These findings provide crucial insights into the molecular mechanisms underlying Canavan disease and the broader principles of protein homeostasis.
What Problem Does This Paper Address?
Canavan disease, a severe neurological disorder, is caused by mutations in the ASPA gene. While it's known that some disease-causing mutations lead to protein instability and degradation, the precise mechanisms and the full spectrum of variant effects remain unclear. Predicting the pathogenicity of genetic variants is a significant challenge, especially for recessive disorders where loss-of-function is the primary mechanism. This paper aims to address this by systematically characterizing the impact of nearly all possible single amino acid substitutions and nonsense mutations in ASPA on its abundance, stability, and cellular toxicity in human cells, providing a detailed map of variant effects.
Methods
The core of this research is a deep mutational scanning (DMS) approach, specifically variant abundance by massively parallel sequencing (VAMP-seq). This technique involves:
- Library Construction: Creating a library of ASPA variants, each tagged with a unique DNA barcode. This library is fused to a GFP reporter.
- Expression and Sorting: Transfecting human HEK293T cells with this library. Cells are then sorted using fluorescence-activated cell sorting (FACS) based on the GFP signal, which reflects the abundance of the expressed ASPA variant. Non-integrated plasmids are eliminated.
- Barcode Sequencing: Sequencing the barcodes of the sorted cells to quantify the relative abundance of each ASPA variant.
- Toxicity Assay: A separate assay measures the competitive fitness of variants over time in culture. Variants that lead to a decrease in cell population are considered toxic.
- Computational Predictions: The experimental data is correlated with predictions from computational tools for thermodynamic stability (Rosetta) and evolutionary conservation (GEMME).
- Degron Mapping: The ASPA protein sequence was divided into tiles to identify regions that, when exposed, trigger degradation signals (degrons).
Datasets
- ASPA Variant Library: A library encompassing 6152 out of 6260 (~98%) possible single amino acid substitutions and nonsense variants of human ASPA.
- Human HEK293T Cells: Used as the cellular system for expressing and analyzing ASPA variants.
- Computational Predictions:
- Rosetta: Used to predict changes in thermodynamic folding stability (ΔΔG) for missense variants.
- GEMME: Used to predict evolutionary conservation scores.
- Public Databases: ClinVar and gnomAD were used to curate lists of known pathogenic, benign, and variant of uncertain significance (VUS) ASPA variants.
Key Insights and Ideas
- Degradation as a Primary Pathogenic Mechanism: The study strongly suggests that for many ASPA variants, particularly those with low abundance, the primary cause of reduced cellular function is not just altered enzymatic activity but rapid degradation by the cell's protein quality control (PQC) system.
- Toxicity of Destabilized Variants: While not directly causing Canavan disease (a recessive disorder), unstable ASPA variants that are not efficiently degraded can become toxic upon prolonged expression, leading to reduced cell fitness. This highlights a secondary consequence of PQC failure.
- Buried Degrons: Degradation signals (degrons) that trigger the PQC system are often located in buried regions of the protein structure. This implies that protein unfolding events transiently expose these normally hidden signals.
- C-terminus as a Degron: The C-terminal region of ASPA appears to function as a degron, contributing to the degradation of unstable variants.
- Correlation, Not Causation: While thermodynamic stability and evolutionary conservation correlate with variant abundance, they don't fully explain all observed effects, underscoring the complexity of protein fate and the importance of experimental DMS.
Key Results
- Comprehensive Variant Coverage: The study successfully characterized the abundance of ~98% of all possible single amino acid substitutions and nonsense variants of ASPA.
- Bimodal Abundance Distribution: Variant abundance scores showed a bimodal distribution, with a peak of stable, wild-type-like variants and a peak of low-abundance variants, often corresponding to nonsense mutations.
- Correlation with Stability and Conservation: Abundance scores showed moderate correlations with predicted thermodynamic stability (Spearman's ρ = -0.47) and evolutionary conservation (Spearman's ρ = 0.45).
- Ubiquitin-Proteasome System (UPS) Dominance: Inhibition studies revealed that most low-abundance ASPA variants are targeted for degradation by the UPS, with minimal involvement of autophagy.
- Degron Mapping: Identified specific regions within ASPA that act as degrons, often located in buried structural areas.
- Distinguishing Pathogenic Variants: The abundance map effectively distinguished known pathogenic variants from benign ones, with most pathogenic variants showing reduced abundance.
- Toxicity Linked to Low Abundance: Toxic variants were almost exclusively found among the low-abundance variants, indicating that toxicity is a consequence of prolonged expression of unstable proteins.
Limitations and Future Work
- Cellular Context: The study used HEK293T cells, which do not express endogenous ASPA. The PQC response might differ in cell types more relevant to Canavan disease, such as oligodendrocytes.
- NAA Concentration: The effect of the ASPA substrate (NAA) on variant distribution was tested, but intracellular NAA concentrations were not precisely controlled, limiting definitive conclusions.
- Resolution of Low-Abundance Variants: The study notes that the resolution for very low-abundance variants was poorer, potentially due to toxicity effects and limitations in FACS binning. Future work could involve sorting into more bins.
- E3 Ligase Identification: While the UPS is implicated, the specific E3 ubiquitin ligases responsible for ASPA degradation remain unidentified, representing a key area for future research.
- Enzyme Activity Measurement: The study focused on abundance and toxicity. Directly measuring the enzymatic activity of variants would provide a more complete picture of pathogenicity, especially for variants that are stable and abundant but functionally impaired.
- Clinical Relevance of Toxicity: The toxicity observed in this assay is unlikely to be directly responsible for Canavan disease but serves as a valuable indicator of protein instability and PQC burden. Understanding the molecular basis of this toxicity could inform broader strategies for managing protein misfolding diseases.
Summary updated